Category: Pharmaceuticals - Page 2
Specialty Prescribing: Why Specialists Choose Brand-Name Drugs Over Generics
Specialists often choose brand-name drugs over cheaper alternatives because of limited data on biosimilars, complex patient needs, and systemic barriers. These drugs treat serious conditions where safety trumps cost.
Future Biosimilars: Upcoming Patent Expirations and Market Entry
Biosimilars are set to transform healthcare as major biologics like Keytruda and Eylea lose patent protection. With billions in savings on the horizon, learn how these complex drugs are entering the market and what it means for patients and providers.
Presumed Consent in Pharmacy: When Pharmacists Can Swap Brand Drugs for Generics Without Asking
In 43 U.S. states, pharmacists can swap brand-name drugs for generics without asking you. Learn how presumed consent laws work, which drugs are safe to switch, and how to protect yourself from risky substitutions.
Stability Testing for Generics: FDA Requirements Explained
Learn exactly what the FDA requires for stability testing of generic drugs, including batch sizes, testing schedules, common rejection reasons, and 2025 updates. Understand how to avoid delays in ANDA approval.
Bridging Studies for NTI Generics: Ensuring Safety and Efficacy in High-Risk Medications
Bridging studies for NTI generics ensure that high-risk medications like warfarin and levothyroxine are as safe and effective as their brand-name versions. Learn why these studies are stricter, costlier, and more complex than for standard generics.
International Reference Pricing: How Countries Set Generic Drug Prices
International reference pricing helps countries control generic drug costs by comparing prices across nations. Learn how it works, which countries use it, and the real-world impact on availability, prices, and patient access.
Generic Patent Case Law: Landmark Court Decisions That Shape Drug Prices
Landmark court decisions like Amgen v. Sanofi and Allergan v. Teva are reshaping how generic drugs enter the market, directly impacting drug prices and patient access. These cases define the legal boundaries between innovation and competition.
Predicting Generic Entry: How to Forecast When Your Drug Gets Generic Competitors
Learn how to predict when generic drugs will enter the market after patent expiration, using real data from FDA filings, litigation, and pricing trends to avoid costly forecasting mistakes.
Glyset (Miglitol) vs Alternative Diabetes Medications - A Detailed Comparison
Compare Glyset (miglitol) with other alpha‑glucosidase inhibitors and diabetes drugs, covering effectiveness, side effects, dosing, and best use cases.
Omnacortil (Prednisolone) vs Alternatives: Detailed Comparison
A detailed guide comparing Omnacortil (prednisolone) with other steroid options, covering potency, side‑effects, uses, and how to choose the right medication.